新型靶向 CD44 的嵌合抗原受体介导 NK 细胞清除卵巢癌细胞
NK Cell-Mediated Eradication of Ovarian Cancer Cells with a Novel Chimeric Antigen Receptor Directed against CD44.
卵巢癌是发达国家中最常见的妇科癌症相关死亡原因。
31.3分
★☆☆☆☆
DISEASE HUB
FOR TREATMENT
按「中国试验优先 → 正在招募 → 更新更近」排序。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
NK Cell-Mediated Eradication of Ovarian Cancer Cells with a Novel Chimeric Antigen Receptor Directed against CD44.
卵巢癌是发达国家中最常见的妇科癌症相关死亡原因。
MEMBER ACCOUNT
登录成功会直接打开下一页。